First Clinical Report on the Treatment of Parkinson’s Disease with Fetal Midbrain Precursor Cells

First Clinical Report on the Treatment of Parkinson’s Disease with Fetal Midbrain Precursor Cells
Mov Disord. 2023 Jan 24. doi: 10.1002/mds.29316. Online ahead of print.ABSTRACTBACKGROUND: Because human fetal ventral mesencephalic tissue grafts provide promising results in ameliorating Parkinson's disease-implicated motor dysfunctions, human fetal midbrain-derived dopamine neuronal precursor cells are considered good candidates for cell-based therapy for Parkinson's disease in that large quantities of cells can be supplied through a good manufacturing practice-compliant system.OBJECTIVE: We ... read more
Source: PubMedPublished on 2023-01-24By Joopyoung Kim